SoldierCrab
7 years agoMember
Trailwire study about hot flushes...
OK someone sent me this knowing I am BC survivor I am not on AI but
https://www.geomap-clinicaltrialfinder.com/nct03518138-au-hot-flushes/?fbclid=IwAR1VazAVmQ4InTY8fNBiLKNndKmvBZb6ByZCcbuAfu54l0DpPsgQy1tXyhM
https://www.trialwirecontact.com/hot-flashes-au-usa/
I thought some of you might be interested I have put the link here that is the quoted page I have copied below for you as it has the hosptials conducting the trials..
https://www.geomap-clinicaltrialfinder.com/nct03518138-au-hot-flushes/?fbclid=IwAR1VazAVmQ4InTY8fNBiLKNndKmvBZb6ByZCcbuAfu54l0DpPsgQy1tXyhM
https://www.trialwirecontact.com/hot-flashes-au-usa/
I thought some of you might be interested I have put the link here that is the quoted page I have copied below for you as it has the hosptials conducting the trials..
Here are the participating clinics in Australia. Please choose your preferred or nearest.*
- SYDNEY Women’s Health and Research Institute of Australia
- SYDNEY Royal North Shore Hospital
- MELBOURNE School of Public Health and Preventive Medicine
- MELBOURNE The Royal Womens Hospital
- PERTH, NedlandS, Sir Charles Gairdner Hospital
- ADELAIDE Royal Adelaide Hospital
HOT FLASHES STUDY (NCT03518138 AU USA)
You can register your interest in this breast cancer and hot flashes study here, and get a call back from the Study Coordinator (NCT03518138 AU USA)
There was a problem with your submission. Errors have been highlighted below.
- Firstly, would you like the link for this study information?
- Yes please send me the link so I can share with friends or my medical specialist
- Eligibility check - Please check the following applies to you (source ClincalTrials.Gov)
- Be a female, aged between 18 - 70 years on the day of informed consent
- Have a history of or current breast cancer and currently taking tamoxifen or an aromatase inhibitor
- On a stable dose of TAM or an AI for a minimum of 30 days before the Screening Visit and no anticipated need to change the dose for the duration of the study
- Experience an average of at least 50 moderate to severe hot flashes/week for the 2 weeks immediately preceding the Run-In Visit (i.e., during the Screening period).
- If on thyroid medication, on a stable dose for a minimum of 30 days before the Screening Visit and no anticipated need to change the dose for the duration of the study
- If taking an SSRI or SNRI, on a stable dose for a minimum of 30 days before the Screening Visit and no anticipated need to change the dose for the duration of the study
- Willing and able to complete the daily participant diary, attend all study visits, and participate in all study procedures
- Able to provide informed consent
- I have checked the eligibility criteria*
- Confirmed
This field is required. - Let's find your nearest participating clinic.*
- See the participating clinics in the UNITED STATES
- See the participating clinics in AUSTRALIA
- Here are the participating clinics in Australia. Please choose your preferred or nearest.*
- SYDNEY Women’s Health and Research Institute of Australia
- SYDNEY Royal North Shore Hospital
- MELBOURNE School of Public Health and Preventive Medicine
- MELBOURNE The Royal Womens Hospital
- PERTH, NedlandS, Sir Charles Gairdner Hospital
- ADELAIDE Royal Adelaide Hospital
Please note: These are all HREC registered and approved participating hospitals and clinics. - When is the best time to contact you?*
- Morning?
- Afternoon?
- Before or after work?
- During work hours?
- Your name*Your name and contact details will ONLY be sent to the clinic team.
- Your email*(Please always check your junk folder if you don't get an email back from the Study Coordinator)
- Do you want the clinic contact details also?*
- Yes please
- No thanks
TECHNICAL SUPPORT
If you are having technical problems, please contact us at Team@Trial-Wire.com